RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.18%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.19B
AUM Growth
+$4.19B
(+0.79%)
Cap. Flow
+$31.2M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
34.6%
Holding
124
New
3
Increased
47
Reduced
8
Closed
3
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$18.3M |
| 2 |
Biomea Fusion
BMEA
|
$17.6M |
| 3 |
Revolution Medicines
RVMD
|
$15.2M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$14.5M |
| 5 |
Pliant Therapeutics
PLRX
|
$13.1M |
Top Sells
| 1 |
Baxter International
BAX
|
$58.6M |
| 2 |
Penumbra
PEN
|
$20.8M |
| 3 |
Align Technology
ALGN
|
$18.4M |
| 4 |
Immunocore
IMCR
|
$15.8M |
| 5 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$13.7M |
Sector Composition
| 1 | Healthcare | 97.18% |
| 2 | Consumer Staples | 1.05% |
| 3 | Industrials | 0.87% |
